Home > Healthcare > Medical Devices > Therapeutic Devices > Home Infusion Therapy Market
Home infusion therapy market from the infusion pumps segment is anticipated to reach USD 39.5 billion by 2032. Diabetes is a growing concern across developed economies. According to the World Health Organization (WHO), incidences of diabetes have been rising over the last decade, with nearly 422 million cases in 2021. Infusion pumps enable at-home administration of drugs including insulin, nutrients, fluids, antibiotics, and other medications in controlled dosages. Increasing incidences of diabetes due to fast-paced lifestyles and unhealthy dietary habits will accelerate the need for advanced insulin pumps.
Home infusion therapy market from the anti-infective application segment is projected to expand at over 10.5% CAGR between 2023 and 2032. Anti-infective home infusion therapy is commonly prescribed to patients with ailments like chronic urinary tract infections (UTIs). As per data published by the American Urology Foundation, in 2021, around 8 million individuals in the U.S. consulted physicians for chronic UTIs. Growing concerns associated with infectious diseases such as cellulitis, abscesses, pneumonia, and catheter sepsis will further boost product uptake across healthcare facilities.
North America home infusion therapy market is poised to surpass USD 30 billion by 2032. The region is expected to witness robust demand for home infusion therapy services owing to rising incidences of chronic diseases. A large patient pool of Alzheimer’s disease will fuel the need for home infusion pumps in countries such as the U.S. and Canada. Additionally, the presence of leading industry players will showcase lucrative scope for technological advancements and the development of innovative therapy in the region. U.S. home infusion therapy industry is poised to depict over 10% CAGR through 2023-2032.